Perspective · 30 Jan 2025
Conference abstractPublished 12 Dec 2017
The digital pathology inside Immunoscore colon
HalioDx, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ImmunoscoreÃ?® quantifies the immune infiltrate within the microenvironment of the tumor. It is assessed by IHC and digital pathology on FFPE colon cancer (CC) tissue. The ImmunoscoreÃ?® is intended as an aid for clinicians to assess prognosis of CC at diagnosis, in combination with the tumor staging (AJCC/UICC-TNM classification). For each patient, 2 slides are stained with primary anti-CD3 & anti-CD8 monoclonal antibodies respectively. Following digitization, virtual slides obtained using a whole slide scanner are analyzed by a dedicated software (ImmunoscoreÃ?® Analyzer) able to calculate a score from CD3- and CD8-positive T cells densities in the invasive margin and core tumor regions. The ImmunoscoreÃ?® provides a score defined as low when low densities of both cell types are found in both regions, intermediate when densities are moderate and high when high densities are found in both regions. Whereas the software is designed to allow the expert-driven reclassification of tissue types (tumor, normal tissue and epithelium) which are necessary to compute the ImmunoscoreÃ?®, the software also proposes an automated classification. Therefore, a recurring question is âÂ?Â?how robust would the ImmunoscoreÃ?® be if digital pathology steps are performed without any human supervision?âÂ? This question was answered by the high overall agreement (92% [85 - 96] over the three-classes of ImmunoscoreÃ?®) between the automated classification with and without edition by a Pathologist.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Immunoscore colon clinical validation and clinical utility in stage II and stage III colon cancer patients
Conference abstract · 2017
F-CALPROTECTIN HELPS REDUCING COSTS AND RISKS FOR PATIENTS IN THE DIAGNOSIS OF COLONIC PATHOLOGY: A PROSPECTIVE REAL-LIFE STUDY FROM THE CLINICAL HOSPITAL OF ZARAGOZA
Conference abstract · 13 Jul 2015
Applying a homology concept to detect regions of interest from colonic digital images
Commentary · 1 Jul 2026
Computational Pathology: Advancing Microscopic Diagnosis Through Intelligent Digital Analysis
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 24 Feb 2025
Combining Urinary Biomarker Panels and Machine Learning For Earlier Detection of Pancreatic Cancer
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Emmanuel G Prestat”
